Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PROTAC probe-assisted degradomics identifies SPINT2 as a candidate cellular target involved in the anti-cancer activity of Flupentixol. | Bioorg Chem | 2026 | 42826660 | PubTator, text mining | PubMed |
| Validation of Optimal Reference Genes for qRT-PCR in Adipose- and Uterine-Derived Feline Mesenchymal Stem Cells. | Vet Sci | 2026 | 42797937 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of cyanoenone- and enone-fused 4-androstene-3,17-dione derivatives against triple-negative breast cancer. | Bioorg Chem | 2026 | 42748754 | PubTator, text mining | PubMed |
| UPS-mediated P-glycoprotein regulation in Alzheimer's disease: pharmacological implications for the amyloid pathology. | Mol Biol Rep | 2026 | 42704522 | PubTator, text mining | PubMed |
| Acute Intermittent Porphyria with a Secondary Porphyria Cutanea Tarda-like Biochemical Pattern in a Patient with Co-Morbid Human Immunodeficiency Virus Infection. | EJIFCC | 2026 | 42698978 | PubTator, text mining | PubMed |
| Sex-specific signatures of fetal programming for gestational diabetes mellitus in umbilical cord: A cohort study from Tanzania. | BMC Med | 2026 | 42629565 | PubTator, text mining | PubMed |
| RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1. | J Med Chem | 2026 | 42417401 | PubTator, text mining | PubMed |
| Limited benefit of liver transplantation in a boy with biallelic severe deficiency of hydroxymethylbilane synthase and review of prior reported cases. | Mol Genet Metab Rep | 2026 | 42396593 | PubTator, text mining | PubMed |
| Sarcopenia and Frailty in COPD: Mechanisms, Relationship with Malnutrition and Potential Therapeutic Interventions. | Nutrients | 2026 | 42356388 | PubTator, text mining | PubMed |
| A Case Report of Acute Intermittent Porphyria Accompanied by Severe Peripheral Neuropathy. | Diagnostics (Basel) | 2026 | 42351467 | PubTator, text mining | PubMed |
| Reprogramming of Iron and Oxygen Metabolism Across the Spectrum of Primary Aldosteronism. | medRxiv | 2026 | 42326790 | PubTator, text mining | PubMed |
| Identification and Validation of Hub Ferroptosis‑Related Genes in Sepsis: An Integrated Bioinformatics and Experimental Study. | Curr Mol Med | 2026 | 42257259 | PubTator, text mining | PubMed |
| Ubiquitin's code: UPS orchestrating DNA repair and genomic stability under genotoxic stress. | Mol Cell Biochem | 2026 | 42118426 | PubTator, text mining | PubMed |
| Updates to gene-disease classifications and inheritance patterns for porphyrias. | Mol Genet Metab | 2026 | 42107342 | PubTator, text mining | PubMed |
| Acute Intermittent Porphyria Triggered by COVID-19 Mimicking Guillain-Barré Syndrome: A Diagnostic Challenge. | Clin Case Rep | 2026 | 42093711 | PubTator, text mining | PubMed |
| Severe peripheral neuropathy secondary to acute intermittent porphyria caused by a rare HMBS gene mutation: a case report. | BMC Neurol | 2026 | 42067825 | PubTator, text mining | PubMed |
| Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma. | Haematologica | 2026 | 42021688 | PubTator, text mining | PubMed |
| Sialic acid cis-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity. | Oncoimmunology | 2026 | 41928453 | PubTator, text mining | PubMed |
| Combining 5-ALA-PDT with berbamine as an in vitro multimodal therapy approach against bladder cancer cells. | Sci Rep | 2026 | 41922474 | PubTator, text mining | PubMed |
| The ribosome-associated N-terminal acetyltransferase B coordinates global proteostasis and autophagy in plants by creating Ac/N-degrons. | Nat Commun | 2026 | 41917016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers